Our focus is patients, 
Our passion is innovation®

MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.


Advanced Science 
Practical Design

We specialize in innovative technologies with proven ease-of-use and patient acceptance.


Inhalation Treatments

Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.


In Partnership
Your Drug, Our Delivery.

Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.


About Us

MannKind Corporation (NASDAQ and TASE: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  More


facebook-c_130x50      twitter_130x50



MannKind Corporation

2017 Annual Meeting of Stockholders

held on May 18, 2017.



FDA Approved

For information about AFREZZA®,
please visit www.AFREZZA.com.